We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Guidance for healthcare professionals covers the use, management and safety of in vitro diagnostic (IVD) devices, including blood glucose meters.
A retrospective cohort study involving a review of records maintained under the National Diabetes Control Programme
Advice and guidance on the health needs of migrant patients for healthcare practitioners
Falsified, potentially harmful Ozempic▼ and Saxenda products have been found in the UK.
Chief Medical Officer for England, Professor Chris Whitty's annual reports and lectures on medicine and public health.
The Scientific Advisory Committee on Nutrition recommendations on carbohydrates, including sugars and fibre
Millions at risk from 'silent killer' as NHS campaign warns there are often 'no clues' when it comes to high blood pressure.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Progress report on the sugar reduction programme between 2015 and 2018, principally for the food industry and public health bodies.
Globally, diabetes contributes to 15% of TB burden and is a risk factor for unfavourable TB treatment outcomes
Guidance to hospital blood banks (HBBs) on flexible approaches to requirements
Tools and resources to plan and deliver blood pressure services in England.
These documents explain how OHID is approaching reduction and food and drink reformulation as part of the government’s obesity strategy.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (21 May 2024) launched a four-week consultation which will support improved safety for certain high risk in vitro diagnostic (IVD) devices.
For the first time in the UK, obese patients and people who are overweight with weight-related health problems could now have access to Mounjaro, currently used for Type 2 diabetes, to help manage their weight and support weight loss.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).